This conference is designed and intended for people with metastatic breast cancer and those who have had breast cancer, nurses, healthcare professionals and others who participate in the care of patients with metastatic breast cancer.
In the US, it’s estimated that over 154,000 women have metastatic breast cancer. Metastatic breast cancer (also called stage IV or advanced breast cancer) is breast cancer that has spread beyond the breast to other organs in the body (most often the bones, lungs, liver or brain).
Eric P. Winer, M.D., is Professor of Medicine at Harvard Medical School, Senior Vice President for Medical Affairs and the Chief Clinical Strategy Officer, Chief, Division of Breast Oncology, and the Thompson Chair in Breast Cancer Research at Dana-Farber Cancer Institute. He is the Director of the Breast Oncology Program for the Dana-Farber/Harvard Cancer Center and the Program Director for the Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer. Dr. Winer is the 2009 recipient of the A. Clifford Barger Excellence in Mentoring Award from Harvard Medical School. In 2016 he received the William L. McGuire Memorial Lecture Award at the San Antonio Breast Cancer Symposium for significant contributions to breast cancer research, and he was the 2017 recipient of the Gianni Bonadonna Award at the annual meeting of the American Society of Clinical Oncology. He is the 2018 Brinker Lecturer at the San Antonio Breast Cancer Symposium. Dr. Winer has devoted his professional career to the treatment of individuals with breast cancer and breast cancer research. His group at Dana-Farber cares for thousands of individuals with breast cancer each year and has an extensive research portfolio with the goal of extending the lives of individuals with breast cancer and minimizing suffering and morbidity from the disease
8:00 am - 4:30 pm
Sheraton Hotel Bloomington